Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on DENDREON CORPORATION
2015Valeant Approved to Buy Dendreon Assets for $495 Million
DJ
2015Drugmaker Valeant close to buying Salix - source
RE
2015VALEANT SECURES FINANCING FOR POTENT : Bloomberg
RE
2015Energy Future Fights for Control of its Bankruptcy -- Week Ahead
DJ
2015DENDREON : Valeant to buy Dendreon's prostate cancer vaccine Provenge
RE
2014DENDREON CORPORATION : A New Combined Approach to Cancer Immunotherapy is Needed
AC
2014DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
AC
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014DENDREON : Reaches Agreements on Terms of Financial Restructuring
BU
2014Feature - As music sales fall, sax player Kenny G turns to stockpicking
RE
2014DENDREON : Names W. Thomas Amick President and Chief Executive Officer
BU
2014DENDREON : Announces Leadership Transition
BU
2014DENDREON : Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associ..
BU
2014DENDREON : Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno..
BU
2014DENDREON : Announces First Quarter 2014 Results
BU
2014DENDREON CORPORATION : quaterly earnings release
2014DENDREON : to Host Conference Call on May 8 to Announce First Quarter Financial ..
BU
2014DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
BU
2014Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
RE
2014Dendreon shares jump on news of prostate drug's European launch
RE
2014DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
PU
2014DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
BU
2014DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2013 Year End Resul..
BU
2014DENDREON CORPORATION : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP ..
PR
2014DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
BU
2014DENDREON CORPORATION : Dendreon to Host Conference Call on March 3 to Announce F..
BU
2014DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
PU
2014DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
BU
2014DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2013 Revenu..
BU
2014DENDREON CORPORATION : Dendreon Announces Change to Presentation Date and Time a..
BU
2014DENDREON CORPORATION : Dendreon Announces Webcast Presentation at J.P. Morgan He..
BU
2013DENDREON CORPORATION : Clinical Studies Updates, and Stock Price Movements - Res..
PR
2013DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Deutsche Bank ..
BU
2013D. E. SHAW & CO. LP 3Q 13F : Largest Eliminations -2-
DJ
2013D. E. SHAW & CO. LP 3Q 13F : Largest Eliminations
DJ
2013S.A.C. CAPITAL ADVISORS LP 3Q 13F : Largest Sales -2-
DJ
2013S.A.C. CAPITAL ADVISORS LP 3Q 13F : Largest Sales
DJ
2013FIDELITY MANAGEMENT & RESEARCH CO. 3 : -2-
DJ
2013FIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Eliminations
DJ
2013DENDREON CORPORATION : Dendreon Announces Third Quarter 2013 Results
BU
2013DENDREON CORPORATION : quaterly earnings release
2013DENDREON CORPORATION : Five Star Equities Issues New Research Reports on DNDN, E..
AC
2013DENDREON CORPORATION : Dendreon, Maker of Provenge, Seeking Buyer -Bloomberg
DJ
2013DENDREON CORPORATION : Market Briefing: Emerging Growth NASDAQ Stocks in the New..
PR
2013DENDREON CORPORATION : Dendreon to Host Conference Call on November 12 to Announ..
BU
2013DENDREON CORPORATION : Announces Presentation of PROVENGE® (sipuleucel-T) Data a..
BU
2013DENDREON CORPORATION : Dendreon Announces Marketing Authorization for PROVENGE® ..
BU
2013DENDREON CORPORATION : Wall Street Fundamentals Releases New In-Depth Stock Repo..
AC
2013DENDREON CORPORATION : Wall Street Fundamentals Releases New In-Depth Stock Repo..
AC
2013DENDREON CORPORATION : Dendreon Announces Second Quarter 2013 Results
BU
2013DENDREON CORPORATION : Dendreon to Host Conference Call on August 8 to Announce ..
BU
2013U.S. HOT STOCK FUTURES : Hot stocks to watch
DJ
2013DENDREON CORPORATION : Dendreon Receives Positive Opinion for PROVENGE® in the E..
BU
2013DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
BU
2013Analysis - A hard day to be a short-seller, one of many this year
RE
2013DENDREON CORPORATION : Dendreon Announces First Quarter 2013 Results
BU
2013DENDREON CORPORATION : StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, an..
AC
2013DENDREON CORPORATION : PROVENGE® (sipuleucel-T) Data Presented at An Annual Scie..
BU
2013DENDREON CORPORATION : Dendreon to Host Conference Call on May 9 to Announce Fir..
BU
2013DENDREON CORPORATION : Dendreon Announces Securities Class Action Settlement
BU
2013DENDREON CORPORATION : Dendreon Announces Webcast Presentation at ROTH Conferenc..
BU
2013DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2012 Year End Resul..
BU
2013DENDREON CORPORATION : quaterly earnings release
2013Glaxo Research Chief Looks Ahead to Next Wave of New Medicines
DJ
2013DENDREON CORPORATION : New PROVENGE® (sipuleucel-T) Data to Be Presented at 2013..
BU
2013DENDREON CORPORATION : Dendreon to Host Conference Call on February 25 to Announ..
BU
2013Wall Street ends flat as rally slows, earnings eyed
RE
2013DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2012 Revenu..
BU
2012DENDREON CORPORATION : Dendreon Sells New Jersey Immunotherapy Manufacturing Fac..
BU
2012DENDREON CORPORATION : Dendreon Announces Webcast Presentations at Upcoming Conf..
BU
2012DENDREON CORPORATION : Dendreon Appoints Lindsay Rocco to Lead Corporate Communi..
BU
1  2  3  4Next
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | US24823Q1076 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Craig R. Jalbert President, Secretary, Treasurer & Director
William Monteith Executive Vice President-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
DENDREON CORPORATION0
CELLTRION, INC.--.--%31 274
IQVIA HOLDINGS INC0.17%20 671
LONZA GROUP-6.84%18 497
NEKTAR THERAPEUTICS50.95%14 892
INCYTE CORPORATION-26.02%14 841